探讨药包材中苯类溶剂残留问题的来源

Discussion on the problems of the source of drug packaging in benzene solvent residues

本文从药包材材料、印刷油墨类型、相关法律法规出发,探讨了药包材中苯类溶剂残留可能的来源,发现从目前市场上收集到的部分无苯油墨中检测出有苯类溶剂(主要为甲苯)残留,部分药包材企业生产中所用的油墨原料并未达到工信部及YBB标准中有关无苯溶剂残留的要求,导致部分药包材产品中苯类溶剂残留量超标。并且食、药包材相关标准中尚无对油墨原料进行规定,质检系统也没有强制规定印刷用油墨中应无苯类溶剂残留,药包材印刷所用油墨的生产处于交叉监管的盲区。

In this paper,drug packaging materials,printing ink types,relevant laws and regulations,are discussed. The possible sources of drug packaging in benzene solvent residues are found to be detected from the current collection on the market portion of benzene ink in benzene solvent（ mainly toluene）. Residual ink part of drug packaging materials used in the production did not meet the remaining requirements of the Ministry of Industry and YBB standards in benzene solvent,resulting in some drug packaging products benzene solvent residues exceeded. Not only food and medicine package material related standards didn＇t specify ink raw materials,but also quality control systems for the printing ink had no mandatory provisions benzene solvent residue. The regulation of drug packaging printing ink production is in the cross-blind area.